WELLS FARGO & COMPANY/MN
Position in HRTX — Heron Therapeutics, Inc. /De/
CIK 72971
SAN FRANCISCO, CA
Position in HRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$65,755
+$12,522 QoQ
Shares Held
152,923
+129.8% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 160 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,774,320 across 417 Biotechnology names. HRTX ranks #294 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in HRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,755 | 152,923 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $53,233 | 66,543 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $233,505 | 179,620 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $155,145 | 123,132 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $534,571 | 258,248 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $169,764 | 77,166 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $114,387 | 74,763 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $121,777 | 61,195 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $212,106 | 60,602 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $114,577 | 41,364 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $63,497 | 37,352 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $31,423 | 30,509 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $60,648 | 52,284 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $46,588 | 30,854 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $24,942 | 9,977 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $58,019 | 13,749 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $127,885 | 45,838 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $578,215 | 101,087 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $950,540 | 104,112 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,807,560 | 169,089 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,584,745 | 166,543 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,797,832 | 110,909 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $4,441,486 | 209,801 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $3,280,034 | 221,325 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $3,927,686 | 267,008 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $830,885 | 70,774 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||